Consensus on the exercise and dosage variables of an exercise training programme for chronic non-specific neck pain: protocol for an international e-Delphi study.

Clinical guidelines and systematic reviews recommend exercise in the management of chronic non-specific neck pain. Although exercise training programmes that consist of both motor control exercise and exercises for the superficial cervical muscles (segmental exercises) are effective, the exercise variables including dosage vary considerably across trials or are poorly reported.

This study aims to gain expert consensus on these exercise variables so that they can be described clearly using intervention reporting checklists to inform clinical practice and future clinical trials.This protocol for an international Delphi study is informed by the Guidance on Conducting and REporting DElphi Studies recommendations and published to ensure quality, rigour and transparency.

The study will consist of three rounds using anonymous online questionnaires. Expert exercise professionals (physiotherapists, strength and conditioning coaches and so on) and academics in neck pain management will be identified through literature searches, peer referral and social media calls for expression of interest. In round 1, participants will answer open-ended questions informed by intervention and exercise reporting checklists. Responses will be analysed thematically by two independent reviewers.

In round 2, participants will rate their level of agreement with statements generated from round 1 and previous clinical trials using a 5-point Likert scale where 1=strongly disagree and 5=strongly agree. In round 3, participants will re-rate their agreement with statements that achieved consensus in round 2. Statements reaching consensus among participants must meet progressively increased a priori criteria at rounds 2 and 3, measured using descriptive statistics: median, IQR and percentage agreement.

Human NOP58 Ribonucleoprotein (NOP58) ELISA Kit

abx381850-96tests Abbexa 96 tests 1093.2 EUR

NOP58 Antibody

DF13192 Affbiotech 200ul 420 EUR

NOP58 siRNA

20-abx926153 Abbexa
  • 661.20 EUR
  • 878.40 EUR
  • 15 nmol
  • 30 nmol

NOP58 siRNA

20-abx926154 Abbexa
  • 661.20 EUR
  • 878.40 EUR
  • 15 nmol
  • 30 nmol

NOP58 Antibody

1-CSB-PA896703LA01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against NOP58. Recognizes NOP58 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF; Recommended dilution: WB:1:500-1:5000, IF:1:50-1:200

NOP58 Antibody

1-CSB-PA015940GA01HU Cusabio
  • 716.40 EUR
  • 399.60 EUR
  • 150ul
  • 50ul
Description: A polyclonal antibody against NOP58. Recognizes NOP58 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

NOP58 antibody

70R-18924 Fitzgerald 50 ul 522 EUR
Description: Rabbit polyclonal NOP58 antibody

NOP58 siRNA

20-abx903599 Abbexa
  • 661.20 EUR
  • 878.40 EUR
  • 15 nmol
  • 30 nmol

NOP58 Blocking Peptide

DF13192-BP Affbiotech 1mg 234 EUR

anti- NOP58 antibody

FNab05796 FN Test 100µg 606.3 EUR
Description: Antibody raised against NOP58

NOP5/NOP58 antibody

70R-3412 Fitzgerald 50 ug 560.4 EUR
Description: Rabbit polyclonal NOP5/NOP58 antibody raised against the middle region of NOP5/NOP58

NOP58 Rabbit pAb

A14129-100ul Abclonal 100 ul 369.6 EUR

NOP58 Rabbit pAb

A14129-200ul Abclonal 200 ul 550.8 EUR

NOP58 Rabbit pAb

A14129-20ul Abclonal 20 ul 219.6 EUR

NOP58 Rabbit pAb

A14129-50ul Abclonal 50 ul 267.6 EUR

NOP58 Polyclonal Antibody

30604-100ul SAB 100ul 302.4 EUR

NOP58 Polyclonal Antibody

30604-50ul SAB 50ul 224.4 EUR

NOP58 Polyclonal Antibody

28438-100ul SAB 100ul 302.4 EUR

NOP58 Polyclonal Antibody

28438-50ul SAB 50ul 224.4 EUR

NOP58 Rabbit pAb

A4749-100ul Abclonal 100 ul 369.6 EUR

NOP58 Rabbit pAb

A4749-200ul Abclonal 200 ul 550.8 EUR

NOP58 Rabbit pAb

A4749-20ul Abclonal 20 ul 219.6 EUR

NOP58 Rabbit pAb

A4749-50ul Abclonal 50 ul 267.6 EUR

NOP58 Polyclonal Antibody

A54768 EpiGentek 100 µg 684.66 EUR
Description: kits suitable for this type of research

Anti-NOP58 antibody

PAab05796 Lifescience Market 100 ug 426 EUR

pDONR223-NOP58 Plasmid

PVTB01144-1 Lifescience Market 2 ug 427.2 EUR

Anti-NOP58 antibody

STJ24780 St John's Laboratory 100 µl 332.4 EUR
Description: The protein encoded by this gene is a core component of box C/D small nucleolar ribonucleoproteins. Some box C/D small nucleolar RNAs (snoRNAs), such as U3, U8, and U14, are dependent upon the encoded protein for their synthesis. This protein is SUMOylated, which is necessary for high affinity binding to snoRNAs.

Anti-NOP58 antibody

STJ116064 St John's Laboratory 100 µl 332.4 EUR
Description: The protein encoded by this gene is a core component of box C/D small nucleolar ribonucleoproteins. Some box C/D small nucleolar RNAs (snoRNAs), such as U3, U8, and U14, are dependent upon the encoded protein for their synthesis. This protein is SUMOylated, which is necessary for high affinity binding to snoRNAs.

NOP58 Polyclonal Conjugated Antibody

C30604 SAB 100ul 476.4 EUR

Rat NOP58 shRNA Plasmid

20-abx986026 Abbexa
  • 961.20 EUR
  • 1345.20 EUR
  • 150 µg
  • 300 µg

NOP58 Polyclonal Conjugated Antibody

C28438 SAB 100ul 476.4 EUR

Human NOP58 shRNA Plasmid

20-abx959853 Abbexa
  • 961.20 EUR
  • 1345.20 EUR
  • 150 µg
  • 300 µg

Mouse NOP58 shRNA Plasmid

20-abx974581 Abbexa
  • 961.20 EUR
  • 1345.20 EUR
  • 150 µg
  • 300 µg

NOP58 Antibody, HRP conjugated

1-CSB-PA896703LB01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against NOP58. Recognizes NOP58 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

NOP58 Antibody, FITC conjugated

1-CSB-PA896703LC01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against NOP58. Recognizes NOP58 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

NOP58 Antibody, Biotin conjugated

1-CSB-PA896703LD01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against NOP58. Recognizes NOP58 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

NOP5/NOP58 Blocking Peptide

33R-5398 Fitzgerald 100 ug 216 EUR
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NOP5/NOP58 antibody, catalog no. 70R-3412

NOP58 ELISA KIT|Human

EF001287 Lifescience Market 96 Tests 826.8 EUR

NOP58 Recombinant Protein (Human)

RP021472 ABM 100 ug Ask for price

NOP58 Recombinant Protein (Rat)

RP214229 ABM 100 ug Ask for price

NOP58 Recombinant Protein (Mouse)

RP154577 ABM 100 ug Ask for price

Human Nucleolar protein 58 (NOP58)

1-CSB-EP896703HU Cusabio
  • 456.00 EUR
  • 256.80 EUR
  • 1570.80 EUR
  • 672.00 EUR
  • 1047.60 EUR
  • 314.40 EUR
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Nucleolar protein 58(NOP58) expressed in E.coli

NOP58 Polyclonal Antibody, Biotin Conjugated

A54765 EpiGentek 100 µg 684.66 EUR
Description: The best epigenetics products

NOP58 Polyclonal Antibody, FITC Conjugated

A54766 EpiGentek 100 µg 684.66 EUR
Description: kits suitable for this type of research

NOP58 Polyclonal Antibody, HRP Conjugated

A54767 EpiGentek 100 µg 684.66 EUR
Description: fast delivery possible

Nop58 ORF Vector (Rat) (pORF)

ORF071411 ABM 1.0 ug DNA 607.2 EUR

NOP58 ORF Vector (Human) (pORF)

ORF007158 ABM 1.0 ug DNA 114 EUR

Nop58 ORF Vector (Mouse) (pORF)

ORF051527 ABM 1.0 ug DNA 607.2 EUR

NOP58 sgRNA CRISPR Lentivector set (Human)

K1441001 ABM 3 x 1.0 ug 406.8 EUR

Nop58 sgRNA CRISPR Lentivector set (Mouse)

K4828601 ABM 3 x 1.0 ug 406.8 EUR

Nop58 sgRNA CRISPR Lentivector set (Rat)

K6841801 ABM 3 x 1.0 ug 406.8 EUR

Human Nucleolar protein 58, NOP58 ELISA KIT

ELI-38275h Lifescience Market 96 Tests 988.8 EUR

Mouse Nucleolar protein 58, Nop58 ELISA KIT

ELI-38276m Lifescience Market 96 Tests 1038 EUR

NOP58 sgRNA CRISPR Lentivector (Human) (Target 1)

K1441002 ABM 1.0 ug DNA 184.8 EUR

NOP58 sgRNA CRISPR Lentivector (Human) (Target 2)

K1441003 ABM 1.0 ug DNA 184.8 EUR

NOP58 sgRNA CRISPR Lentivector (Human) (Target 3)

K1441004 ABM 1.0 ug DNA 184.8 EUR

Nop58 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4828602 ABM 1.0 ug DNA 184.8 EUR

Nop58 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4828603 ABM 1.0 ug DNA 184.8 EUR

Nop58 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4828604 ABM 1.0 ug DNA 184.8 EUR

Nop58 sgRNA CRISPR Lentivector (Rat) (Target 1)

K6841802 ABM 1.0 ug DNA 184.8 EUR

Nop58 sgRNA CRISPR Lentivector (Rat) (Target 2)

K6841803 ABM 1.0 ug DNA 184.8 EUR

Nop58 sgRNA CRISPR Lentivector (Rat) (Target 3)

K6841804 ABM 1.0 ug DNA 184.8 EUR

NOP58 Protein Vector (Human) (pPB-C-His)

PV028629 ABM 500 ng 394.8 EUR

NOP58 Protein Vector (Human) (pPB-N-His)

PV028630 ABM 500 ng 394.8 EUR

NOP58 Protein Vector (Human) (pPM-C-HA)

PV028631 ABM 500 ng 394.8 EUR

NOP58 Protein Vector (Human) (pPM-C-His)

PV028632 ABM 500 ng 394.8 EUR

Human Nucleolar protein 58(NOP58)ELISA Kit

QY-E03190 Qayee Biotechnology 96T 472.8 EUR

NOP58 Protein Vector (Rat) (pPB-C-His)

PV285642 ABM 500 ng 723.6 EUR

NOP58 Protein Vector (Rat) (pPB-N-His)

PV285643 ABM 500 ng 723.6 EUR

NOP58 Protein Vector (Rat) (pPM-C-HA)

PV285644 ABM 500 ng 723.6 EUR

NOP58 Protein Vector (Rat) (pPM-C-His)

PV285645 ABM 500 ng 723.6 EUR

NOP58 Protein Vector (Mouse) (pPB-C-His)

PV206106 ABM 500 ng 723.6 EUR

NOP58 Protein Vector (Mouse) (pPB-N-His)

PV206107 ABM 500 ng 723.6 EUR

NOP58 Protein Vector (Mouse) (pPM-C-HA)

PV206108 ABM 500 ng 723.6 EUR

NOP58 Protein Vector (Mouse) (pPM-C-His)

PV206109 ABM 500 ng 723.6 EUR

Nop58 3'UTR Luciferase Stable Cell Line

TU214085 ABM 1.0 ml Ask for price

Nop58 3'UTR GFP Stable Cell Line

TU264085 ABM 1.0 ml Ask for price

NOP58 3'UTR Luciferase Stable Cell Line

TU015825 ABM 1.0 ml 1825.2 EUR

Nop58 3'UTR Luciferase Stable Cell Line

TU114212 ABM 1.0 ml Ask for price

Nop58 3'UTR GFP Stable Cell Line

TU164212 ABM 1.0 ml Ask for price

NOP58 3'UTR GFP Stable Cell Line

TU065825 ABM 1.0 ml 1825.2 EUR

NOP58 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV692263 ABM 1.0 ug DNA 818.4 EUR

NOP58 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV692267 ABM 1.0 ug DNA 818.4 EUR

NOP58 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV692268 ABM 1.0 ug DNA 818.4 EUR

Recombinant Candida Albicans NOP58 Protein (aa 1-516)

VAng-Lsx05762-inquire Creative Biolabs inquire Ask for price
Description: Candida Albicans (strain SC5314 / ATCC MYA-2876) Nucleolar protein 58, recombinant protein.

NOP58 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K1441005 ABM 3 x 1.0 ug 451.2 EUR

Nop58 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K4828605 ABM 3 x 1.0 ug 451.2 EUR

Nop58 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6841805 ABM 3 x 1.0 ug 451.2 EUR

NOP58 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV692264 ABM 1.0 ug DNA 818.4 EUR

NOP58 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV692265 ABM 1.0 ug DNA 888 EUR

NOP58 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV692266 ABM 1.0 ug DNA 888 EUR

NOP58 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K1441006 ABM 1.0 ug DNA 200.4 EUR

NOP58 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K1441007 ABM 1.0 ug DNA 200.4 EUR

NOP58 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K1441008 ABM 1.0 ug DNA 200.4 EUR

Nop58 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K4828606 ABM 1.0 ug DNA 200.4 EUR

Nop58 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K4828607 ABM 1.0 ug DNA 200.4 EUR

Nop58 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K4828608 ABM 1.0 ug DNA 200.4 EUR

Nop58 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6841806 ABM 1.0 ug DNA 200.4 EUR

Nop58 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6841807 ABM 1.0 ug DNA 200.4 EUR

Nop58 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6841808 ABM 1.0 ug DNA 200.4 EUR

Inferential statistics will be used to evaluate measures of agreement between participants (Kendall’s coefficient of concordance) and stability between rounds (Wilcoxon rank-sum test). Statements achieving consensus in round 3 will provide expert recommendations of the key exercise and dosage variables in the management of chronic non-specific neck pain.Ethical approval was provided by the University of Birmingham Ethics Committee (Ref:ERN_19-1857). Results will be disseminated through peer-reviewed publications and conference presentations.